Commonwealth Equity Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.2M | Sell |
|
|||||
|
2025
Q2 | $32.8M | Buy |
|
|||||
|
2025
Q1 | $26.3M | Sell |
|
|||||
|
2024
Q4 | $35.2M | Sell |
|
|||||
|
2024
Q3 | $51.1M | Sell |
|
|||||
|
2024
Q2 | $72.2M | Buy |
|
|||||
|
2024
Q1 | $52.5M | Buy |
|
|||||
|
2023
Q4 | $24.5M | Buy |
|
|||||
|
2023
Q3 | $17.8M | Buy |
|
|||||
|
2023
Q2 | $15.3M | Buy |
|
|||||
|
2023
Q1 | $13K | Buy |
|
|||||
|
2022
Q4 | $10.5M | Sell |
|
|||||
|
2022
Q3 | $7.78M | Buy |
|
|||||
|
2022
Q2 | $8.64M | Sell |
|
|||||
|
2022
Q1 | $9.57M | Sell |
|
|||||
|
2021
Q4 | $9.78M | Sell |
|
|||||
|
2021
Q3 | $8.6M | Sell |
|
|||||
|
2021
Q2 | $7.65M | Buy |
|
|||||
|
2021
Q1 | $6.1M | Buy |
|
|||||
|
2020
Q4 | $5.93M | Buy |
|
|||||
|
2020
Q3 | $5.51M | Buy |
|
|||||
|
2020
Q2 | $5.11M | Buy |
|
|||||
|
2020
Q1 | $4.64M | Sell |
|
|||||
|
2019
Q4 | $4.75M | Buy |
|
|||||
|
2019
Q3 | $3.75M | Sell |
|
|||||
|
2019
Q2 | $3.85M | Sell |
|
|||||
|
2019
Q1 | $5.34M | Buy |
|
|||||
|
2018
Q4 | $4.54M | Buy |
|
|||||
|
2018
Q3 | $4.48M | Sell |
|
|||||
|
2018
Q2 | $4.4M | Sell |
|
|||||
|
2018
Q1 | $4.75M | Sell |
|
|||||
|
2017
Q4 | $5.19M | Sell |
|
|||||
|
2017
Q3 | $4.9M | Sell |
|
|||||
|
2017
Q2 | $4.4M | Buy |
|
|||||
|
2017
Q1 | $2.85M | Buy |
|
|||||
|
2016
Q4 | $2.85M | Buy |
|
|||||
|
2016
Q3 | $2.6M | Buy |
|
|||||
|
2016
Q2 | $3.2M | Sell |
|
|||||
|
2016
Q1 | $3.22M | Sell |
|
|||||
|
2015
Q4 | $3.5M | Buy |
|
|||||
|
2015
Q3 | $2.96M | Buy |
|
|||||
|
2015
Q2 | $2.9M | Buy |
|
|||||
|
2015
Q1 | $2.83M | Sell |
|
|||||
|
2014
Q4 | $2.27M | Buy |
|
|||||
|
2014
Q3 | $2.47M | Buy |
|
|||||
|
2014
Q2 | $2.37M | Buy |
|
|||||
|
2014
Q1 | $2.1M | Buy |
|
|||||
|
2013
Q4 | $1.68M | Buy |
|
|||||
|
2013
Q3 | $1.51M | Buy |
|
|||||
|
2013
Q2 | $1.3M | Buy |
|